NVCR

Novocure

• Simply Wall St·3d ago

  Should NovoCure’s (NVCR) Upgraded Momentum Score and Earnings Revisions Require Action From Investors?

• NASDAQ·5d ago

  Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice

• Simply Wall St·08/18 08:26

  What’s Behind NovoCure (NVCR) Shares Climbing Today?

• Simply Wall St·08/12 09:22

  NovoCure (NVCR) Is Up 8.5% After Advancing Tumor Treating Fields Pipeline And Trials Progress - Has The Bull Case Changed?

• Simply Wall St·08/11 03:36

  NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued

• NASDAQ·08/07 12:59

  4 Healthcare Stocks to Watch as Defensive Demand Strengthens

• Simply Wall St·07/30 03:26

  NovoCure (NVCR) Stock Looks Undervalued With Shares Down 90% Over Five Years

• TipRanks·07/27 09:00

  Analysts Are Bullish on These Healthcare Stocks: Codexis (CDXS), RegenXBio (RGNX)

• Simply Wall St·07/26 13:30

  NovoCure (NVCR) Is Up 10.9% After Raising 2026 Revenue Outlook and Securing New CE Mark Approval – Has The Bull Case Changed?

• Simply Wall St·07/25 00:42

  NovoCure (NVCR) Stock Faces Ongoing Losses As Q2 2026 EPS Narrows To $0.13 Loss

• Seeking Alpha·07/24 17:45

  NovoCure: Why I'm Fading The Q2 Earnings Rally

• Benzinga·07/24 15:08

  NovoCure's Strongest Quarter Ever Isn't Enough to Stop NVCR Stock From Sliding

• Seeking Alpha·07/24 14:21

  NovoCure's Clean Beat Signals A Shift Toward Profitability (Rating Upgrade)

• Dow Jones·07/24 13:02

  Novocure Is Maintained at Neutral by Wedbush

• Benzinga·07/24 12:51

  Wedbush Maintains Neutral on NovoCure, Raises Price Target to $20